Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-25 @ 9:52 PM
Study NCT ID:
NCT01596751
Status:
COMPLETED
Last Update Posted:
2020-07-17
First Post:
2012-05-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
Sponsor:
Hope Rugo, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07-12
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-05
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-07
First Submit QC Date:
None
Study First Post Date:
2012-05-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-01
Results First Submit QC Date:
None
Results First Post Date:
2020-05-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-02
Last Update Post Date:
2020-07-17
Last Update Post Date Type:
ACTUAL